Diaz Luis
Insider CIK 1720081 · DGX Director · JNCE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DGX QUEST DIAGNOSTICS INC | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 5,196 | SEC↗ |
| DGX QUEST DIAGNOSTICS INC | A Award | 2025-05-15 | 2025-05-19 | 1,203 | — | $0 | 4,054 | SEC↗ |
| DGX QUEST DIAGNOSTICS INC | A Award | 2024-05-16 | 2024-05-20 | 1,482 | — | $0 | 2,851 | SEC↗ |
| DGX QUEST DIAGNOSTICS INC | A Award | 2023-05-17 | 2023-05-19 | 1,369 | — | $0 | 1,369 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 20,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 27,100 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 10,163 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-06-24 | 2022-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-06-18 | 2021-06-22 | 15,700 | — | $0 | 15,700 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-07-02 | 15,700 | — | $0 | 15,700 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-06-29 | 13,550 | — | $0 | 13,550 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-13 | 15,700 | — | $0 | 15,700 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 10,163 | — | $0 | 10,163 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2017-10-20 | 2017-10-23 | 27,100 | — | $0 | 27,100 | SEC↗ |